These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8373935)

  • 1. Adverse reactions to aspartame: double-blind challenge in patients from a vulnerable population.
    Walton RG; Hudak R; Green-Waite RJ
    Biol Psychiatry; 1993 Jul 1-15; 34(1-2):13-7. PubMed ID: 8373935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspartame is no more likely than placebo to cause urticaria/angioedema: results of a multicenter, randomized, double-blind, placebo-controlled, crossover study.
    Geha R; Buckley CE; Greenberger P; Patterson R; Polmar S; Saxon A; Rohr A; Yang W; Drouin M
    J Allergy Clin Immunol; 1993 Oct; 92(4):513-20. PubMed ID: 8409113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspartame ingestion and headaches: a randomized crossover trial.
    Van den Eeden SK; Koepsell TD; Longstreth WT; van Belle G; Daling JR; McKnight B
    Neurology; 1994 Oct; 44(10):1787-93. PubMed ID: 7936222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Adverse reactions to aspartame: double-blind challenge in patients from a vulnerable population" by Walton et al.
    Butchko HH
    Biol Psychiatry; 1994 Aug; 36(3):206-8. PubMed ID: 7948460
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspartame and susceptibility to headache.
    Schiffman SS; Buckley CE; Sampson HA; Massey EW; Baraniuk JN; Follett JV; Warwick ZS
    N Engl J Med; 1987 Nov; 317(19):1181-5. PubMed ID: 3657889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combined single-blind, double-blind, placebo-controlled study to determine the reproducibility of hypersensitivity reactions to aspartame.
    Garriga MM; Berkebile C; Metcalfe DD
    J Allergy Clin Immunol; 1991 Apr; 87(4):821-7. PubMed ID: 2013676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspartame and seizure susceptibility: results of a clinical study in reportedly sensitive individuals.
    Rowan AJ; Shaywitz BA; Tuchman L; French JA; Luciano D; Sullivan CM
    Epilepsia; 1995 Mar; 36(3):270-5. PubMed ID: 7614911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspartame sensitivity? A double blind randomised crossover study.
    Sathyapalan T; Thatcher NJ; Hammersley R; Rigby AS; Courts FL; Pechlivanis A; Gooderham NJ; Holmes E; le Roux CW; Atkin SL
    PLoS One; 2015; 10(3):e0116212. PubMed ID: 25786106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspartame use by persons with diabetes.
    Nehrling JK; Kobe P; McLane MP; Olson RE; Kamath S; Horwitz DL
    Diabetes Care; 1985; 8(5):415-7. PubMed ID: 3902420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
    Lecrubier Y; Clerc G; Didi R; Kieser M
    Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial.
    Soares CN; Almeida OP; Joffe H; Cohen LS
    Arch Gen Psychiatry; 2001 Jun; 58(6):529-34. PubMed ID: 11386980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspartame use in Parkinson's disease.
    Karstaedt PJ; Pincus JH
    Neurology; 1993 Mar; 43(3 Pt 1):611-3. PubMed ID: 8451009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression.
    Marangell LB; Martinez JM; Zboyan HA; Kertz B; Kim HF; Puryear LJ
    Am J Psychiatry; 2003 May; 160(5):996-8. PubMed ID: 12727707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurobehavioral effects of aspartame consumption.
    Lindseth GN; Coolahan SE; Petros TV; Lindseth PD
    Res Nurs Health; 2014 Jun; 37(3):185-93. PubMed ID: 24700203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of aspartame in non-insulin-dependent diabetics.
    Stern SB; Bleicher SJ; Flores A; Gombos G; Recitas D; Shu J
    J Toxicol Environ Health; 1976 Nov; 2(2):429-39. PubMed ID: 1011296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylphenidate in mild depression: a double-blind controlled trial.
    Mattes JA
    J Clin Psychiatry; 1985 Dec; 46(12):525-7. PubMed ID: 3905773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspartame: neuropsychologic and neurophysiologic evaluation of acute and chronic effects.
    Spiers PA; Sabounjian L; Reiner A; Myers DK; Wurtman J; Schomer DL
    Am J Clin Nutr; 1998 Sep; 68(3):531-7. PubMed ID: 9734727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind study of bupropion and placebo in depression.
    Feighner JP; Meredith CH; Stern WC; Hendrickson G; Miller LL
    Am J Psychiatry; 1984 Apr; 141(4):525-9. PubMed ID: 6422779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.
    Schmidt PJ; Daly RC; Bloch M; Smith MJ; Danaceau MA; St Clair LS; Murphy JH; Haq N; Rubinow DR
    Arch Gen Psychiatry; 2005 Feb; 62(2):154-62. PubMed ID: 15699292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of PRX-00023, a novel, selective serotonin 1A receptor agonist on measures of anxiety and depression in generalized anxiety disorder: results of a double-blind, placebo-controlled trial.
    Rickels K; Mathew S; Banov MD; Zimbroff DL; Oshana S; Parsons EC; Donahue SR; Kauffman M; Iyer GR; Reinhard JF
    J Clin Psychopharmacol; 2008 Apr; 28(2):235-9. PubMed ID: 18344738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.